Cite
Why are ototopical aminoglycosides still first-line therapy for chronic suppurative otitis media? A systematic review and discussion of aminoglycosides versus quinolones
MLA
A S Harris, et al. “Why Are Ototopical Aminoglycosides Still First-Line Therapy for Chronic Suppurative Otitis Media? A Systematic Review and Discussion of Aminoglycosides versus Quinolones.” The Journal of Laryngology and Otology, vol. 130, no. 1, Nov. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....80846de33aec82ba04a5eaa3b15fe250&authtype=sso&custid=ns315887.
APA
A S Harris, H A Elhassan, & E P Flook. (2015). Why are ototopical aminoglycosides still first-line therapy for chronic suppurative otitis media? A systematic review and discussion of aminoglycosides versus quinolones. The Journal of Laryngology and Otology, 130(1).
Chicago
A S Harris, H A Elhassan, and E P Flook. 2015. “Why Are Ototopical Aminoglycosides Still First-Line Therapy for Chronic Suppurative Otitis Media? A Systematic Review and Discussion of Aminoglycosides versus Quinolones.” The Journal of Laryngology and Otology 130 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....80846de33aec82ba04a5eaa3b15fe250&authtype=sso&custid=ns315887.